2023
Black and Hispanic Individuals with Tourette Syndrome are Under-Represented in Specialty Clinics (P11-11.016)

Marisela Dy-Hollins , Lori Chibnik , Evan Realbuto , Vinod Rao
Neurology 100 ( 17 Supplement 2)

2023
Assessing Sex Differences in Individuals with Tourette Syndrome and Persistent Motor or Vocal Tic Disorder (S42. 009)

Marisela Dy-Hollins , Lori Chibnik , Lisa Osiecki , Nutan Sharma
Neurology 100 ( 17 Supplement 2)

2023
Association between psychological resilience and cognitive function in older adults: Effect modification by inflammatory status

Sun Jae Jung , Ga Bin Lee , Kristen Nishimi , Lori Chibnik
Geroscience 43 ( 6) 2749 -2760

19
2021
Sex-specific association of the X chromosome with cognitive change and tau pathology in aging and Alzheimer disease

Emily J Davis , Caroline W Solsberg , Charles C White , Elena Miñones-Moyano
JAMA neurology 78 ( 10) 1249 -1254

46
2021
GENETIC INTERACTION REGULATES ISOFORM-SPECIFIC EXPRESSION OF AN ALZHEIMER'S DISEASE RISK GENE AND AFFECTS BRAIN STRUCTURAL CONNECTIVITY

Daniel Felsky , Jishu Xu , Lori Chibnik , Julie Schneider
EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 S284 -S285

2017
Genetic Interaction between SORL1 and BDNF Regulates Isoform-Specific SORL1 Expression with Effects on Brain Structure and Amyloid Pathology

Daniel Felsky , Jishu Xu , Lori Chibnik , Julie Schneider
NEUROPSYCHOPHARMACOLOGY 40 S470 -S471

2015
Early Surgical Menopause Is Associated with a Spectrum of Cognitive Decline (S24. 003)

Riley Bove , Elizabeth Secor , Lori Chibnik , Lisa Barnes
Neurology 80 ( 7 Supplement) S24. 003 -S24. 003

2013
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis

Melanie Quintana , Benjamin R Saville , Matteo Vestrucci , Michelle A Detry
Annals of Neurology 94 ( 3) 547 -560

6
2023
Results from the first four regimens of the HEALEY ALS Platform Trial (PL5. 004)

Sabrina Paganoni , James Berry , Melanie Quintana , Eric Macklin
Neurology 100 ( 17 Supplement 2)

2
2023
Pridopidine For the Treatment of ALS-Top Line Results From the Phase 2 Healey ALS Platform Trial

Jeremy M Shefner , Bjorn Oskarsson , Michal Geva , Yael Cohen
MUSCLE & NERVE 68 S61 -S61

1
2023
Pridopidine for the Treatment of ALS—Results from the Phase 2 Healey ALS Platform Trial (S5. 003)

Jeremy Shefner , Bjorn Oskarsson , Yael Cohen , Kelly Chen
Neurology 102 ( 17_supplement_1) 6524 -6524

2024
CNM-Au8 Treatment Results in Significant Difference in Plasma Neurofilament Light Chain (NfL) Levels vs. Placebo in the HEALEY ALS Platform Trial

James Berry , Nicholas Maragakis , Sabrina Paganoni , Melanie Quintana
MUSCLE & NERVE 68 S60 -S60

2023
Multiple types of distress are prospectively associated with increased risk of ovarian cancer

Andrea L Roberts , Andrew Ratanatharathorn , Lori Chibnik , Laura D Kubzansky
Cancer Medicine 12 ( 14) 15404 -15413

1
2023
26. UNRAVELING THE HETEROGENEITY OF PTSD SYMPTOMS THROUGH IDENTIFYING EPIGENETIC SUBTYPES AMONG TRAUMA-EXPOSED CIVILIAN WOMEN

Yiwen Zhu , Jiaxuan Liu , Andrew Ratanatharathorn , Karmel Choi
European Neuropsychopharmacology 75 S71 -S71

2023
Genetic Interaction between SORL1 and BDNF Regulates Isoform-Specific SORL1 Expression and Brain Amyloid

Daniel Felsky , Jishu Xu , Lori Chibnik , Julie A Schneider
BIOLOGICAL PSYCHIATRY 79 ( 9) 95S -95S

2016
BEYOND BORDERS: INTEGRATING TRAINING AND RESEARCH FOR SCIENTIFIC EXCELLENCE AND GLOBAL EQUITY

Lori Chibnik , Bizu Gelaye , Paola Giusti-Rodriguez
European Neuropsychopharmacology 75 S31 -S32

2023
P1–054: An exploration of a functional unit of DNA methylation in the aging brain

Brendan Keenan , Gyan Srivastava , Lori Chibnik , Philip De Jager
Alzheimer's & Dementia 9 P172 -P172

3
2013